How it works?
Senza categoria

Safety of PEGylated Hyaluronic Acid Filler for theTreatment of Facial Skin Aging: Case Report


et al. Paweł Kubik


Clinical Case Reports International


DESCRIPTION

Background: The face is the area most exposed to the normal course of skin aging, both intrinsically and extrinsically.

Aim: The aim of the case report was to evaluate the cellular and clinical response of a therapeutic protocol aimed at countering facial skin aging.


Materials and Methods: One female patient with facial skin laxity and photodamage underwent treatment protocol of implementation of PEG-cross-linked hyaluronic acid soft tissue fillers.


Results: The histological results at 0, 7, 14 and 21 days after the procedure showed an increase in the number of fibroblasts and angiogenesis, at the same time it was shown that the treatment has an immunomodulating action.


Conclusion: A treatment with PEG-cross-linked hyaluronic acid leads to numerous positive cutaneous changes after histological and immunological evaluations.


Back



Diapath Lab Talks | Privacy Policy